Pradaxa User Wins $542K Verdict In Conn. Bellwether Trial

By Daniel Siegal (May 20, 2019, 10:47 PM EDT) -- A Connecticut jury on Friday handed Boehringer Ingelheim Pharmaceuticals its first loss in several bellwether trials in a consolidated proceeding over the alleged bleeding risk of its blood thinner Pradaxa, finding the drug caused a man's internal bleeding and awarding him over $500,000 plus punitive damages....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!